SGMOQ as of Nov 1 · 03:01 ET
SGMOQOTCBiological Products, (No Diagnostic Substances)

Sangamo Therapeutics, Inc · Brief

Next report

5 days

Nov 6 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
—≥ implied
Aug 6 '24—▼−13.46%—
Nov 12 '24—▼−9.96%—
Mar 17 '25—▼−16.23%—
Aug 7 '25—▼−5.33%—
Q3 FY25—▼−16.29%—
Q4 FY25—▼−31.33%—
Q1 FY26—▼−19.66%—
May 14 '26—▼−0.37%—
quarterimplied−35%0+35%realized×
May '26—▼−0.37%—
Q1 FY26—▼−19.66%—
Q4 FY25—▼−31.33%—
Q3 FY25—▼−16.29%—
Aug '25—▼−5.33%—
Mar '25—▼−16.23%—
2 older reports
Nov '24—▼−9.96%—
Aug '24—▼−13.46%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 6 report · est.

—

Linked exposure

SGMOQ report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.